Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 15/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | WDR5 | P61964 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366332 | 0.79 | GPR84 (1.00) | GPR84KDM4EMEN1KMT2ARECQL | |
| SCHEMBL29726541 | 0.79 | GPR84 (1.00) | GPR84KDM4EMEN1KMT2ARECQL | |
| SCHEMBL887292 | 0.79 | GPR84 (0.50) | GPR84KDM4EMEN1KMT2AWDR5 | |
| SCHEMBL296014 | 0.79 | GPR84 (1.00) | GPR84KDM4EMEN1KMT2ARECQL | |
| SCHEMBL887345 | 0.76 | GPR84 (0.69) | GPR84KDM4EMEN1KMT2AWDR5 | |
| SCHEMBL31280085 | 0.76 | GPR84 (0.69) | GPR84KDM4EMEN1KMT2AWDR5 | |
| SCHEMBL887355 | 0.74 | GPR84 (0.43) | GPR84KDM4EMEN1KMT2AWDR5 | |
| Alcohol SCHEMBL15876328 | 0.73 | GPR84 (0.84) | GPR84KDM4EMEN1KMT2ARECQL | |
| SCHEMBL12047109 | 0.73 | GPR84 (0.69) | GPR84KDM4EMEN1KMT2AWDR5 | |
| SCHEMBL3967442 | 0.73 | GPR84 (0.69) | GPR84KDM4EMEN1KMT2AWDR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | GPR84 2711/4885KDM4E 1975/4885MEN1 194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.